TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Biogen Sweden AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
428,897
|
454,786
|
555,659 |
Financial expenses |
54
|
285
|
620 |
Earnings before taxes |
16,441
|
16,035
|
27,323 |
EBITDA |
15,268
|
16,505
|
28,232 |
Total assets |
169,784
|
167,400
|
200,021 |
Current assets |
169,657
|
167,158
|
199,534 |
Current liabilities |
40,411
|
51,135
|
87,219 |
Equity capital |
120,823
|
107,651
|
103,564 |
- share capital |
67
![]() |
67
|
73 |
Employees (average) |
28
|
31
![]() |
31 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
71.2%
|
64.3%
|
51.8% |
Turnover per employee |
15,318
|
14,671
|
17,924 |
Profit as a percentage of turnover |
3.8%
|
3.5%
|
4.9% |
Return on assets (ROA) |
9.7%
![]() |
9.7%
|
14.0% |
Current ratio |
419.8%
|
326.9%
|
228.8% |
Return on equity (ROE) |
13.6%
|
14.9%
|
26.4% |
Change turnover |
-28,231
|
-55,864
|
70,663 |
Change turnover % |
-6%
|
-11%
|
15% |
Chg. No. of employees |
-3
|
0
|
-2 |
Chg. No. of employees % |
-10%
|
0%
|
-6% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.